Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Genome-Wide Analysis of BRD4-Targets Reveals the Therapeutic Relevance of Simultaneous Targeting of BCR Pathway and IKZF-MYC Axis in Mantle Cell Lymphoma

Junya Kuroda, MD PhD, Taku Tsukamoto, MD PhD, Shingo Nakahata, Kazuhiro Morishita, MD PhD, Ryuichi Sato, Akinori Kanai, PhD, Toshiya Inaba, Masakazu Nakano, Kei Tashiro, Masafumi Taniwaki, MD PhD

Blood (2018) 132 (Supplement 1): 4100.

https://doi.org/10.1182/blood-2018-99-109982

Published: 2018

Journal Articles

EVI1 in Acute Myeloid Leukemia Triggers Metabolic Reprograming Associated with Leukemogenesis and Increases Sensitivity to L-Aspalaginase

Yusuke Saito, MD PhD, Daisuke Sawa, MD, Mariko Kinoshita, MD, Ai Yamada, MD, Sachiyo Kamimura, MD, Kazuhiro Morishita, MD PhD, Tomoyoshi Soga, PhD, Hiroshi Moritake, MD PhD

Blood (2018) 132 (Supplement 1): 2601.

https://doi.org/10.1182/blood-2018-99-111581

Published: 2018

Journal Articles

TSP-A74, a Novel Therapeutic Monoclonal Antibody Against TfR1 for Treatment of Hematologic Malignancies

Lilin Zhang, MD PhD, Fumiko Nomura, Youichi Aikawa, Yukio Sudo, PhD, Kazuhiro Morishita, MD PhD, Yoshikazu Kurosawa, PhD

Blood (2016) 128 (22): 5214.

https://doi.org/10.1182/blood.V128.22.5214.5214

Published: 2016

Journal Articles

All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors

Keichiro Mihara, MD PhD, Tetsumi Yoshida, MD, Seiko Ishida, MD PhD, Yoshifumi Takei, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD PhD, Kazuhiro Morishita, MD PhD, Yoshihiro Takihara, MD PhD, Tatsuo Ichinohe, MD

Blood (2015) 126 (23): 591.

https://doi.org/10.1182/blood.V126.23.591.591

Published: 2015

Journal Articles

Adult T-Cell Leukemia/Lymphoma Cells Were Eliminated By T Cells With Anti-CD38 Chimeric Antigen Receptor Through CD38 Expression Induced By All-Trans Retinoic Acid

Tetsumi Yoshida, MD, Keichiro Mihara, MD, PhD, Akira Kitanaka, MD, PhD, Kazuya Shimoda, MD, PhD, Kazuhiro Morishita, MD, PhD, Yoshihiro Takihara, MD, PhD, Tatsuo Ichinohe, MD, PhD

Blood (2013) 122 (21): 1824.

https://doi.org/10.1182/blood.V122.21.1824.1824

Published: 2013

Journal Articles

Recurrent Chromosomal Rearrangements and a Homozygous Deletion Spanning 1-Mb Region at 10p11.2 in Adult T-Cell Leukemia/Lymphoma.

Tomonori Hidaka, MD, Kazuhiro Nishida, MD, PhD, Daisuke Shimizu, MD, Hidenori Sasaki, MD, Kiyoshi Yamashita, MD, Yoko Kubuki, MD, Kenichi Nomura, MD, PhD, Tomohiko Taki, MD, PhD, Hirohito Tsubouchi, MD, PhD, Kazuhiro Morishita, MD, PhD, Masafumi Taniwaki, MD, PhD

Blood (2004) 104 (11): 4275.

https://doi.org/10.1182/blood.V104.11.4275.4275

Published: 2004

NARROW

Genome-Wide Analysis of BRD4-Targets Reveals the Therapeutic Relevance of Simultaneous Targeting of BCR Pathway and IKZF-MYC Axis in Mantle Cell Lymphoma

EVI1 in Acute Myeloid Leukemia Triggers Metabolic Reprograming Associated with Leukemogenesis and Increases Sensitivity to L-Aspalaginase

TSP-A74, a Novel Therapeutic Monoclonal Antibody Against TfR1 for Treatment of Hematologic Malignancies

All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors

Adult T-Cell Leukemia/Lymphoma Cells Were Eliminated By T Cells With Anti-CD38 Chimeric Antigen Receptor Through CD38 Expression Induced By All-Trans Retinoic Acid

Recurrent Chromosomal Rearrangements and a Homozygous Deletion Spanning 1-Mb Region at 10p11.2 in Adult T-Cell Leukemia/Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Genome-Wide Analysis of BRD4-Targets Reveals the Therapeutic Relevance of Simultaneous Targeting of BCR Pathway and IKZF-MYC Axis in Mantle Cell Lymphoma

EVI1 in Acute Myeloid Leukemia Triggers Metabolic Reprograming Associated with Leukemogenesis and Increases Sensitivity to L-Aspalaginase

TSP-A74, a Novel Therapeutic Monoclonal Antibody Against TfR1 for Treatment of Hematologic Malignancies

All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors

Adult T-Cell Leukemia/Lymphoma Cells Were Eliminated By T Cells With Anti-CD38 Chimeric Antigen Receptor Through CD38 Expression Induced By All-Trans Retinoic Acid

Recurrent Chromosomal Rearrangements and a Homozygous Deletion Spanning 1-Mb Region at 10p11.2 in Adult T-Cell Leukemia/Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only